Decision: Favourable

Study Title:

LANDMARK Trial: A prospective, multinational, multicentre, open-label, randomised, non-inferiority trial to compare safety and effectiveness of Meril’s Myval

  • NREC Code:

    22-NREC-MD-006

  • Decision:

    Favourable

  • Meeting Date:

    16/03/2022

  • Study Type:

    MD application

  • Principal Investigator:

    Dr Darren Mylotte

  • PI Institution:

    Galway University Hospital

  • Sponsor:

    Meril Life Sciences Pvt. Ltd

Scroll to Top
Skip to content